Jingjing C. Shao
Zhejiang Provincial Key Laboratory Of Anti Cancer Chinese Medicines And Natural Medicines
Hangzhou, 311121, China
Hangzhou, 311121, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Molecular landscape and clinical translation of DNA damage response alterations in solid tumors: A pan-cancer perspective on precision oncology.
Journal: Neoplasia (New York, N.Y.)
Published: March 17, 2026
β-elemene directly targets IL-17RA in macrophages to inhibit inflammation and attenuate acute pancreatitis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 18, 2026
Ubiquitin-Modifying Enzymes as Cell-Fate Regulators in Intestinal Inflammation.
Journal: International journal of biological sciences
Published: December 23, 2025
Brain Extracellular Space: From an Overlooked Dimension to Catalyst of a Novel Neuroscience Paradigm.
Journal: Cyborg and bionic systems (Washington, D.C.)
Published: December 01, 2025
Unraveling Signaling Pathways in Immune Microenvironment Crosstalk to Overcome Immunotherapy Resistance in Colorectal Cancer.
Journal: Human mutation
Published: November 19, 2025
Microglial Deubiquitinase OTUD7B Stabilizes STAT3 to Promote Neuroinflammation and Cognitive Decline in Alzheimer's Disease.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 13, 2025
Arteannuin B, a novel NLRP3 inhibitor, suppresses NLRP3 inflammasome in macrophages and alleviates NLRP3-related diseases.
Journal: International immunopharmacology
Published: October 25, 2025
JOSD2 alleviates hypertensive renal disease through deubiquitinating AKT in renal tubular epithelial cells.
Journal: Cellular signalling
Published: September 17, 2025
Efficacy of continuing pembrolizumab after progression on first-line treatment in stage IV non-small cell lung cancer: a prospective real-world study.
Journal: American journal of cancer research
Published: September 01, 2025
Immunotherapy strategies targeting tumor-associated macrophages and their mechanisms of action in tumor progression.
Journal: Frontiers in immunology
Published: August 06, 2025
Experimental Investigations on Sustainable Dual-Biomass-Based Composite Phase Change Materials for Energy-Efficient Building Applications.
Journal: Materials (Basel, Switzerland)
Published: July 03, 2025
Isolinderalactone alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation and inflammatory response in macrophages.
Journal: Atherosclerosis
Published: June 27, 2025
Last Updated: 09/26/2026